NZ595227A - Tricyclic indole derivates as pbr ligands - Google Patents
Tricyclic indole derivates as pbr ligandsInfo
- Publication number
- NZ595227A NZ595227A NZ595227A NZ59522710A NZ595227A NZ 595227 A NZ595227 A NZ 595227A NZ 595227 A NZ595227 A NZ 595227A NZ 59522710 A NZ59522710 A NZ 59522710A NZ 595227 A NZ595227 A NZ 595227A
- Authority
- NZ
- New Zealand
- Prior art keywords
- imaging agent
- vivo imaging
- synthesis
- pbr
- tetrahydro
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title abstract 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 239000012216 imaging agent Substances 0.000 abstract 6
- 238000011503 in vivo imaging Methods 0.000 abstract 6
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000003786 synthesis reaction Methods 0.000 abstract 3
- 239000002243 precursor Substances 0.000 abstract 2
- VDAYBLBVZWTNQB-UHFFFAOYSA-N 2-[4-(diethylcarbamoyl)-2-methyl-1,2,3,4-tetrahydrocarbazol-9-yl]ethyl methanesulfonate Chemical compound C12=CC=CC=C2N(CCOS(C)(=O)=O)C2=C1C(C(=O)N(CC)CC)CC(C)C2 VDAYBLBVZWTNQB-UHFFFAOYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- UZKHZSTUQXRUJW-MIGPCILRSA-N n,n-diethyl-11-(2-fluoranylethyl)-8-methoxy-6h-thiochromeno[4,3-b]indole-6-carboxamide Chemical compound C12=CC(OC)=CC=C2N(CC[18F])C2=C1C(C(=O)N(CC)CC)SC1=CC=CC=C12 UZKHZSTUQXRUJW-MIGPCILRSA-N 0.000 abstract 1
- NGMRMYUCJXPRQB-UHFFFAOYSA-N n,n-diethyl-9-(2-fluoroethyl)-2-methyl-1,2,3,4-tetrahydrocarbazole-4-carboxamide Chemical compound C12=CC=CC=C2N(CCF)C2=C1C(C(=O)N(CC)CC)CC(C)C2 NGMRMYUCJXPRQB-UHFFFAOYSA-N 0.000 abstract 1
- 239000012217 radiopharmaceutical Substances 0.000 abstract 1
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 1
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16413109P | 2009-03-27 | 2009-03-27 | |
| GBGB0905328.1A GB0905328D0 (en) | 2009-03-27 | 2009-03-27 | Indole derivatives |
| PCT/EP2010/053998 WO2010109007A2 (en) | 2009-03-27 | 2010-03-26 | Indole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595227A true NZ595227A (en) | 2013-11-29 |
Family
ID=40671850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595227A NZ595227A (en) | 2009-03-27 | 2010-03-26 | Tricyclic indole derivates as pbr ligands |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8790619B2 (enExample) |
| EP (1) | EP2411362B1 (enExample) |
| JP (1) | JP5651163B2 (enExample) |
| KR (1) | KR101692090B1 (enExample) |
| CN (1) | CN102448933B (enExample) |
| AU (1) | AU2010227527B2 (enExample) |
| BR (1) | BRPI1010261A2 (enExample) |
| CA (1) | CA2756887C (enExample) |
| ES (1) | ES2635310T3 (enExample) |
| GB (1) | GB0905328D0 (enExample) |
| IL (1) | IL215019A0 (enExample) |
| MX (1) | MX2011010154A (enExample) |
| NZ (1) | NZ595227A (enExample) |
| RU (1) | RU2525196C2 (enExample) |
| SG (1) | SG174589A1 (enExample) |
| WO (1) | WO2010109007A2 (enExample) |
| ZA (1) | ZA201106708B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| RU2551423C2 (ru) * | 2010-03-26 | 2015-05-27 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Производные трициклического индола в качестве лигандов pbr |
| GB201016038D0 (en) | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
| GB201016411D0 (en) * | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
| GB201021263D0 (en) | 2010-12-15 | 2011-01-26 | Ge Healthcare Ltd | Solid phase extraction method |
| WO2012138894A1 (en) * | 2011-04-05 | 2012-10-11 | Sloan-Kettering Institute For Cancer Research | Hsp90 inhibitors |
| EP2718464A1 (en) | 2011-06-06 | 2014-04-16 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
| AU2012315757B9 (en) * | 2011-09-30 | 2018-01-25 | Ge Healthcare Limited | Calibration and normalization systems and methods for radiopharmaceutical synthesizers |
| RU2015118217A (ru) * | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
| KR20150088803A (ko) | 2012-11-30 | 2015-08-03 | 지이 헬쓰케어 리미티드 | 트리시클릭 인돌을 생성하는 아연 할라이드 매개 고리화 방법 |
| GB201312768D0 (en) * | 2013-07-17 | 2013-08-28 | Ge Healthcare Ltd | Work-up procedure |
| GB201316762D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Ltd | Novel compounds |
| GB201316764D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Ltd | Novel compounds |
| GB201316766D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Uk Ltd | Macrophage Imaging |
| KR102458116B1 (ko) | 2014-12-04 | 2022-10-24 | 지이 헬쓰케어 리미티드 | 방사성 약제로부터의 아세트알데히드의 제거 방법 |
| CN106748802B (zh) * | 2016-12-26 | 2018-11-13 | 南京理工大学 | 一种制备含氟仲胺的方法 |
| CN110997068B (zh) * | 2017-05-24 | 2022-12-06 | 宾夕法尼亚大学董事会 | 用于成像和放射疗法的经放射标记的荧光parp抑制剂 |
| US11200669B2 (en) * | 2019-11-19 | 2021-12-14 | Uih America, Inc. | Systems and methods for determining plasma input function used in positron emission tomography imaging |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3939177A (en) * | 1972-11-22 | 1976-02-17 | Sterling Drug Inc. | 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles |
| US3979391A (en) * | 1972-11-22 | 1976-09-07 | Sterling Drug Inc. | 1,2,3,4-Tetrahydrocarbazoles |
| FR2599740B1 (fr) * | 1986-06-05 | 1988-08-12 | Rhone Poulenc Sante | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant |
| US5270030A (en) * | 1988-12-29 | 1993-12-14 | Bio-Technology General Corp. | Fibrin binding domain polypeptide and method of producing |
| AU1407399A (en) | 1997-11-14 | 1999-06-07 | Eli Lilly And Company | Treatment for alzheimer's disease |
| PT1048651E (pt) * | 1997-12-03 | 2003-09-30 | Taisho Pharmaceutical Co Ltd | Compostos tetraciclicos contendo azoto |
| JPH11228539A (ja) * | 1997-12-03 | 1999-08-24 | Taisho Pharmaceut Co Ltd | 含窒素四環性化合物 |
| AU767009B2 (en) * | 1998-12-11 | 2003-10-30 | Virginia Commonwealth University | Selective 5-HT6 receptor ligands |
| FR2788776B1 (fr) | 1999-01-26 | 2001-02-23 | Synthelabo | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
| GB0115929D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase electrophilic fluorination |
| GB0115927D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
| US7160909B2 (en) | 2001-08-09 | 2007-01-09 | Eli Lilly And Company | Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| JP2005527466A (ja) | 2001-08-09 | 2005-09-15 | イーライ・リリー・アンド・カンパニー | ｓＰＬＡ２インヒビターとしてのシクロヘプトＢインドール誘導体 |
| GB0523506D0 (en) | 2005-11-18 | 2005-12-28 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
-
2009
- 2009-03-27 GB GBGB0905328.1A patent/GB0905328D0/en not_active Ceased
-
2010
- 2010-03-26 RU RU2011138850/04A patent/RU2525196C2/ru active
- 2010-03-26 JP JP2012501315A patent/JP5651163B2/ja active Active
- 2010-03-26 SG SG2011070018A patent/SG174589A1/en unknown
- 2010-03-26 BR BRPI1010261A patent/BRPI1010261A2/pt not_active Application Discontinuation
- 2010-03-26 NZ NZ595227A patent/NZ595227A/xx unknown
- 2010-03-26 EP EP10710356.6A patent/EP2411362B1/en active Active
- 2010-03-26 US US13/258,465 patent/US8790619B2/en active Active
- 2010-03-26 ES ES10710356.6T patent/ES2635310T3/es active Active
- 2010-03-26 KR KR1020117025305A patent/KR101692090B1/ko active Active
- 2010-03-26 AU AU2010227527A patent/AU2010227527B2/en active Active
- 2010-03-26 MX MX2011010154A patent/MX2011010154A/es active IP Right Grant
- 2010-03-26 WO PCT/EP2010/053998 patent/WO2010109007A2/en not_active Ceased
- 2010-03-26 CA CA2756887A patent/CA2756887C/en active Active
- 2010-03-26 CN CN201080023868.3A patent/CN102448933B/zh active Active
- 2010-09-13 US US12/880,218 patent/US8501153B2/en active Active
-
2011
- 2011-09-07 IL IL215019A patent/IL215019A0/en not_active IP Right Cessation
- 2011-09-13 ZA ZA2011/06708A patent/ZA201106708B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5651163B2 (ja) | 2015-01-07 |
| IL215019A0 (en) | 2011-11-30 |
| US8501153B2 (en) | 2013-08-06 |
| RU2525196C2 (ru) | 2014-08-10 |
| ZA201106708B (en) | 2013-02-27 |
| MX2011010154A (es) | 2011-10-21 |
| WO2010109007A3 (en) | 2010-11-25 |
| KR20110133492A (ko) | 2011-12-12 |
| JP2012521973A (ja) | 2012-09-20 |
| GB0905328D0 (en) | 2009-05-13 |
| AU2010227527B2 (en) | 2015-03-12 |
| EP2411362A2 (en) | 2012-02-01 |
| RU2011138850A (ru) | 2013-05-10 |
| KR101692090B1 (ko) | 2017-01-02 |
| US20120020884A1 (en) | 2012-01-26 |
| CN102448933B (zh) | 2014-07-02 |
| AU2010227527A1 (en) | 2011-10-13 |
| WO2010109007A2 (en) | 2010-09-30 |
| ES2635310T3 (es) | 2017-10-03 |
| CA2756887A1 (en) | 2010-09-30 |
| SG174589A1 (en) | 2011-10-28 |
| US8790619B2 (en) | 2014-07-29 |
| CN102448933A (zh) | 2012-05-09 |
| HK1167393A1 (en) | 2012-11-30 |
| US20110070161A1 (en) | 2011-03-24 |
| CA2756887C (en) | 2018-06-19 |
| BRPI1010261A2 (pt) | 2016-03-22 |
| EP2411362B1 (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595227A (en) | Tricyclic indole derivates as pbr ligands | |
| WO2005040337A3 (en) | METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES | |
| UA99257C2 (ru) | Способ получения 3-замещенных 2-амино-5-галогенбензамидов | |
| HRP20191617T1 (hr) | Kombinacija koja sadrži inhibitor mek i inhibitor b-raf | |
| WO2010037851A3 (en) | Indole derivatives suitable for imaging neuroinflammation | |
| NZ594177A (en) | Novel benzodiazepine derivatives | |
| MY150514A (en) | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | |
| MA30950B1 (fr) | Nouveaux (aza) cyclohexanes carbonyles en tant que ligands du recepteur de dopamine d3. | |
| IL180897A (en) | Method for producing a composition comprising hyperpolarized c-13 pyruvate and use thereof as a contrast agent for magnetic resonance imaging | |
| IL207895A0 (en) | A method for detecting igf1r/chr 15 circulating tumor cells using fish | |
| IL206933A0 (en) | Method for preparing adenine compound | |
| AR072994A1 (es) | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos | |
| MX2013008560A (es) | Metodo para preparar derivados de 2-aminobenzamida. | |
| NZ611988A (en) | Solid phase extraction method | |
| EP2279759A3 (en) | Compounds and methods for 18F labeled agents | |
| MY163136A (en) | Peptide radiotracer compositions | |
| WO2011044406A3 (en) | Purification method | |
| MX2011010295A (es) | Reactivos de radiomarcado y metodos. | |
| NZ602025A (en) | Tricyclic indole derivatives as pbr ligands | |
| RU2014109381A (ru) | СПОСОБ ПОЛУЧЕНИЯ КОМПЛЕКСОВ 68Ga | |
| WO2008072976A3 (en) | Synthesis of a radiofluorinated peptide using microwave activation technology | |
| MX2010004300A (es) | Ligandos de (1,4-diaza-biciclo [3,2,2]non-6-en-4-il)-heterociclil- metanona para receptores nicotinicos de acetilcolina, utiles para el tratamiento de enfermedad. | |
| TW200833371A (en) | Process for solid formulations | |
| NI201000144A (es) | Procedimiento de preparación de combretastatina | |
| EA201300719A2 (ru) | Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина и применение в синтезе ивабрадина и его солей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 MAR 2017 BY COMPUTER PACKAGES INC Effective date: 20140328 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2018 BY COMPUTER PACKAGES INC Effective date: 20170302 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2019 BY COMPUTER PACKAGES INC Effective date: 20180302 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2020 BY ANAQUA SERVICES Effective date: 20190219 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2021 BY ANAQUA SERVICES Effective date: 20200219 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2022 BY ANAQUA SERVICES Effective date: 20210217 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2023 BY ANAQUA SERVICES Effective date: 20220218 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2024 BY ANAQUA SERVICES Effective date: 20230222 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2025 BY ANAQUA SERVICES Effective date: 20240220 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 MAR 2026 BY ANAQUA SERVICES Effective date: 20250219 |